BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1139-1145

  Jiang, Jiahua ^a   Thyagarajan Sahu, Anita ^a   Loganathan, Jagadish ^a   Eliaz, Isaac ^b   Terry, Colin ^a   Sandusky, George E ^c   Sliva, Daniel ^a,c,d  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b Amitabha Medical Clinic and Healing Center   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C X C chemokine receptor 4; Dietary supplement; Lung cancer metastasis; Triple negative breast cancer cells; Urokinase plasminogen activator

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BREASTDEFEND; CHEMOKINE RECEPTOR CXCR4; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INHIBITION; CONTROLLED STUDY; CXC CHEMOKINE RECEPTOR 4 GENE; DOSE RESPONSE; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; UROKINASE PLASMINOGEN ACTIVATOR GENE;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; PLANT EXTRACTS; PLANTS, MEDICINAL; RECEPTORS, CXCR4; TOXICITY TESTS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866454139     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1936     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics. CA Cancer J Clin 60: 277-300, 2010.
3. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.
4. Velicer CM and Ulrich CM: Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 26: 665-673, 2008. (Pubitemid 351264364)
5. Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS and Ballard-Barbash R: Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc 108: 483-494, 2008. (Pubitemid 351288619)
6. Jiang J, Wojnowski R, Jedinak A and Sliva D: Suppression of proliferation and invasive behavior of human metastatic breast cancer cells by dietary supplement BreastDefend. Integr Cancer Ther 10: 192-200, 2011.
7. Ho CY, Kim CF, Leung KN, Fung KP, Tse TF, Chan H and Lau CB: Differential anti-tumor activity of Coriolus versicolor (Yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells. Cancer Biol Ther 4: 638-644, 2005.
8. Jiang J, Slivova V and Sliva D: Ganoderma lucidum inhibits proliferation of human breast cancer cells by downregulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 29: 695-703, 2006.
9. Thyagarajan A, Jiang J, Hopf A, Adamec J and Sliva D: Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med 18: 657-664, 2006.
10. Sliva D: Suppression of cancer invasiveness by dietary compounds. Mini Rev Med Chem 8: 677-688, 2008.
11. Bui-Xuan NH, Tang PM, Wong CK and Fung KP: Photo-activated pheophorbide-a, an active component of Scutellaria barbata, enhances apoptosis via the suppression of ERK-mediated autophagy in the estrogen receptor-negative human breast adenocarcinoma cells MDA-MB-231. J Ethnopharmacol 131: 95-103, 2010.
12. Ye MN and Chen HF: Effects of Astragalus injection on proliferation of basal-like breast cancer cell line MDA-MB-468. Zhong Xi Yi Jie He Xue Bao 6: 399-404, 2008.
13. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D and Nguyen M: Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 98: 234-240, 2002. (Pubitemid 34150808)
14. Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vené R, Dell'Eva R, et al: The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19: 137-152, 2007.
15. Schlachterman A, Valle F, Wall KM, Azios NG, Castillo L, Morell L, Washington AV, et al: Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol 1: 19-27, 2008.
16. Castillo-Pichardo L, Martínez-Montemayor MM, Martínez JE, Wall KM, Cubano LA and Dharmawardhane S: Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis 26: 505-516, 2009.
17. Hsu EL, Chen N, Westbrook A, Wang F, Zhang R, Taylor RT and Hankinson O: CXCR4 and CXCL12 down-regulation: a novel mechanism for the chemoprotection of 3,3′-diindolylmethane for breast and ovarian cancers. Cancer Lett 265: 113-123, 2008.
18. Ahmad A, Kong D, Wang Z, Sarkar SH, Banerjee S and Sarkar FH: Down-regulation of uPA and uPAR by 3,3′-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells. J Cell Biochem 108: 916-925, 2009.
19. Elliott BE, Meens JA, SenGupta SK, Louvard D and Arpin M: The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 7: R365-R373, 2005.
20. Gelmann EP, Thompson EW and Sommers CL: Invasive and metastatic properties of MCF-7 cells and rasH-transfected MCF-7 cell lines. Int J Cancer 50: 665-669, 1992.
21. Xue C, Plieth D, Venkov C, Xu C and Neilson EG: The gate-keeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63: 3386-3394, 2003. (Pubitemid 36735899)
22. Vanzulli SI, Soldati R, Meiss R, Colombo L, Molinolo AA and Lanari C: Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression. Carcinogenesis 26: 1055-1063, 2005. (Pubitemid 41214298)
23. Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F, Yan X, et al: TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression. Hum Pathol 38: 293-298, 2007. (Pubitemid 46096554)
24. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498, 2005. (Pubitemid 41507710)
25. Lee WJ, Chen WK, Wang CJ, Lin WL and Tseng TH: Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 226: 178-191, 2008.
26. Ishihara Y, Iijima H and Matsunaga K: Contribution of cytokines on the suppression of lung metastasis. Biotherapy 11: 267-275, 1998. (Pubitemid 29044694)
27. Maehara Y, Tsujitani S, Saeki H, Oki E, Yoshinaga K, Emi Y, Morita M, et al: Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®) ): review of development and future perspectives. Surg Today 42: 8-28, 2012.
28. Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID, Yang KH and Kim HM: The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology 41: 157-164, 1999. (Pubitemid 29099828)
29. Lee HJ, Lee HJ, Lim ES, Ahn KS, Shim BS, Kim HM, Gong SJ, et al: Cambodian Phellinus linteus inhibits experimental metastasis of melanoma cells in mice via regulation of urokinase type plasminogen activator. Biol Pharm Bull 28: 27-31, 2005.
30. Kimura Y, Taniguchi M and Baba K: Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22: 3309-3318, 2002. (Pubitemid 36070107)
31. Nonaka Y, Ishibashi H, Nakai M, Shibata H, Kiso Y and Abe S: Effects of the antlered form of Ganoderma lucidum on tumor growth and metastasis in cyclophosphamide-treated mice. Biosci Biotechnol Biochem 72: 1399-1408, 2008. (Pubitemid 351883775)
32. Chen NH, Liu JW and Zhong JJ: Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol Rep 62: 150-163, 2010.
33. Kim EJ, Shin M, Park H, Hong JE, Shin HK, Kim J, Kwon DY, et al: Oral administration of 3,3′-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J Nutr 139: 2373-2379, 2009.
34. Sliva D, Jedinak A, Kawasaki J, Harvey K and Slivova V: Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer 98: 1348-1356, 2008. (Pubitemid 351543583)
35. Han B, Nakamura M, Mori I, Nakamura Y and Kakudo K: Urokinase-type plasminogen activator system and breast cancer (review). Oncol Rep 14: 105-112, 2005.
36. Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P and Brünner N: Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Cancer Res 61: 532-537, 2001. (Pubitemid 32128612)
37. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)
38. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L and Shim H: Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65: 967-671, 2005.
39. Ma WF, Du J, Fu LP, Fang R, Chen HY and Cai SH: Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis. Mol Cancer Res 7: 1613-1621, 2009.
40. Kim J, Thorne SH, Sun L, Huang B and Mochly-Rosen D: Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model. Oncogene 30: 323-333, 2011.
41. Giricz O, Calvo V, Pero SC, Krag DN, Sparano JA and Kenny PA: GRB7 is required for triple-negative breast cancer cell invasion and survival. Breast Cancer Res Treat: Oct 18, 2011 (Epub ahead of print).
42. Cleator S, Heller W and Coombes RC: Triple-negative breast cancer: therapeutic options. Lancet Oncol 8: 235-244, 2007. (Pubitemid 46291713)